Benedict R. Lucchesi

Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.

Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.

C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion.

Apoptosis in myocardial infarction.

SNC-80-induced preconditioning: selective activation of the mitochondrial adenosine triphosphate-gated potassium channel.

Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator.

Prevention of carotid artery thrombosis after oral administration of the glycoprotein IIb/IIIa antagonist CRL42796.

17Beta-estradiol as a receptor-mediated cardioprotective agent.

Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel.

The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1.

Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis.

Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury.

皮肤 disulfate (Intimatan) 可防止人体血浆灌注兔心脏补体介导心肌损伤。

Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury.

Disodium Disuccinate Astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion.

Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.

Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury.

The antithrombotic effect of melagatran in combination with clopidogrel and/or aspirin (carotid artery primary thrombosis study).

Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase.

Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model.

Effect of sodium/hydrogen exchange inhibition on myocardial infarct size after coronary artery thrombosis and thrombolysis.

Preclinical evaluation of S18886 in an experimental model of coronary arterial thrombosis.

Sulodexide: a renewed interest in this glycosaminoglycan.

Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion.

The pathway-selective estrogen receptor ligand WAY-169916 reduces infarct size after myocardial ischemia and reperfusion by an estrogen receptor dependent mechanism.

Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.

Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart.

Disodium disuccinate astaxanthin prevents carotid artery rethrombosis and ex vivo platelet activation.

Estrogen-mediated protection in myocardial ischemia-reperfusion injury.

Estrogen protects the heart from ischemia-reperfusion injury via COX-2-derived PGI2.

Cardiac arrhythmia and injury induced in rats by burst and pulsed mode ultrasound with a gas body contrast agent.

Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.

Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model.

Are ECG premature complexes induced by ultrasonic cavitation electrophysiological responses to irreversible cardiomyocyte injury?